Hochman David P 4
4 · Orchestra BioMed Holdings, Inc. · Filed Sep 26, 2024
Insider Transaction Report
Form 4
Hochman David P
DirectorSee Remarks
Transactions
- Purchase
Common Stock, par value $0.0001 per share ("Common Stock")
2024-09-24$4.91/sh+2,500$12,275→ 570,498 total - Purchase
Common Stock
2024-09-25$4.86/sh+1,500$7,290→ 335,002 total(indirect: By Trust) - Purchase
Common Stock
2024-09-25$4.74/sh+2,000$9,480→ 2,000 total(indirect: By Trust) - Purchase
Common Stock
2024-09-25$4.70/sh+2,000$9,400→ 2,000 total(indirect: By Trust) - Purchase
Common Stock
2024-09-25$4.73/sh+2,000$9,460→ 2,000 total(indirect: By Trust)
Holdings
- 3,140(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.90 to $4.95. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.83 to $4.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F5]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.